_id

690db07cccc777a4e85d0b85

Ticker

ARDX

Name

Ardelyx Inc

Exchange

NASDAQ

Address

400 Fifth Avenue, Waltham, MA, United States, 02451

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.ardelyx.com

Description

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Last Close

5.92

Volume

2818285

Current Price

5.9

Change

-0.33783783783783067

Last Updated

2025-11-28T12:21:27.706Z

Image

data:image/webp;base64,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

Ipo Date

2014-06-19T00:00:00.000Z

Market Cap

1440837632

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9875

Sentiment Sources

4

Rating

4.6364

Target Price

11.6

Strong Buy

8

Buy

2

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

110329000

Cost Of Revenue

1320000

Gross Profit

109009000

Operating Expenses

104341000

Operating Income

4668000

Interest Expense

5796000

Pretax Income

-867000

Net Income

-969000

Eps

-0.004005648303078611

Dividends Per Share

-

Shares Outstanding

242974306

Income Tax Expense

102000

EBITDA

5834000

Operating Margin

4.230981881463623

Total Other Income Expense Net

-5535000

Cash

42715000

Short Term Investments

199990000

Receivables

76610000

Inventories

25172000

Total Current Assets

367985000

Property Plant Equipment

7221000

Total Assets

486170000

Payables

18390000

Short Term Debt

1435000

Long Term Debt

202138000

Total Liabilities

331890000

Equity

154280000

Depreciation

905000

Change In Working Capital

-9244000

Cash From Operations

365000

Capital Expenditures

156000

Cash From Investing

-50509000

Cash From Financing

2814000

Net Change In Cash

-47330000

PE

-

PB

9.251099308400311

ROE

-0.6280788177339901

ROA

-0.19931299751115866

FCF

209000

Fcf Percent

0.0018943342185644752

Piotroski FScore

2

Health Score

12

Deep Value Investing Score

3.5

Defensive Investing Score

5.5

Dividend Investing Score

3

Economic Moat Investing Score

5.3

Garp Investing Score

3.5

Growth Investing Score

3.5

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

2

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

110329000

Quarters > 0 > income Statement > cost Of Revenue

1320000

Quarters > 0 > income Statement > gross Profit

109009000

Quarters > 0 > income Statement > operating Expenses

104341000

Quarters > 0 > income Statement > operating Income

4668000

Quarters > 0 > income Statement > interest Expense

5796000

Quarters > 0 > income Statement > pretax Income

-867000

Quarters > 0 > income Statement > net Income

-969000

Quarters > 0 > income Statement > eps

-0.004005648303078611

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

241908407

Quarters > 0 > income Statement > income Tax Expense

102000

Quarters > 0 > income Statement > EBITDA

5834000

Quarters > 0 > income Statement > operating Margin

4.230981881463623

Quarters > 0 > income Statement > total Other Income Expense Net

-5535000

Quarters > 0 > balance Sheet > cash

42715000

Quarters > 0 > balance Sheet > short Term Investments

199990000

Quarters > 0 > balance Sheet > receivables

76610000

Quarters > 0 > balance Sheet > inventories

25172000

Quarters > 0 > balance Sheet > total Current Assets

367985000

Quarters > 0 > balance Sheet > property Plant Equipment

7221000

Quarters > 0 > balance Sheet > total Assets

486170000

Quarters > 0 > balance Sheet > payables

18390000

Quarters > 0 > balance Sheet > short Term Debt

1435000

Quarters > 0 > balance Sheet > long Term Debt

202138000

Quarters > 0 > balance Sheet > total Liabilities

331890000

Quarters > 0 > balance Sheet > equity

154280000

Quarters > 0 > cash Flow > net Income

-969000

Quarters > 0 > cash Flow > depreciation

905000

Quarters > 0 > cash Flow > change In Working Capital

-9244000

Quarters > 0 > cash Flow > cash From Operations

365000

Quarters > 0 > cash Flow > capital Expenditures

156000

Quarters > 0 > cash Flow > cash From Investing

-50509000

Quarters > 0 > cash Flow > cash From Financing

2814000

Quarters > 0 > cash Flow > net Change In Cash

-47330000

Quarters > 0 > ratios > PE

-0.004005648303078611

Quarters > 0 > ratios > PB

9.251099308400311

Quarters > 0 > ratios > ROE

-0.6280788177339901

Quarters > 0 > ratios > ROA

-0.19931299751115866

Quarters > 0 > ratios > FCF

209000

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

0.0018943342185644752

Quarters > 0 > health Score

12

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

97662000

Quarters > 1 > income Statement > cost Of Revenue

12403000

Quarters > 1 > income Statement > gross Profit

85259000

Quarters > 1 > income Statement > operating Expenses

99654000

Quarters > 1 > income Statement > operating Income

-14395000

Quarters > 1 > income Statement > interest Expense

6575000

Quarters > 1 > income Statement > pretax Income

-19078000

Quarters > 1 > income Statement > net Income

-19079000

Quarters > 1 > income Statement > eps

-0.07951950032461745

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

239928570

Quarters > 1 > income Statement > income Tax Expense

1000

Quarters > 1 > income Statement > EBITDA

-11872000

Quarters > 1 > income Statement > operating Margin

-14.739612131637688

Quarters > 1 > income Statement > total Other Income Expense Net

-4683000

Quarters > 1 > balance Sheet > cash

90045000

Quarters > 1 > balance Sheet > short Term Investments

148407000

Quarters > 1 > balance Sheet > receivables

62553000

Quarters > 1 > balance Sheet > inventories

22275000

Quarters > 1 > balance Sheet > total Current Assets

351569000

Quarters > 1 > balance Sheet > property Plant Equipment

7149000

Quarters > 1 > balance Sheet > total Assets

466770000

Quarters > 1 > balance Sheet > payables

21685000

Quarters > 1 > balance Sheet > short Term Debt

1182000

Quarters > 1 > balance Sheet > long Term Debt

201446000

Quarters > 1 > balance Sheet > total Liabilities

327239000

Quarters > 1 > balance Sheet > equity

139531000

Quarters > 1 > cash Flow > net Income

-19079000

Quarters > 1 > cash Flow > depreciation

631000

Quarters > 1 > cash Flow > change In Working Capital

-18929000

Quarters > 1 > cash Flow > cash From Operations

-25342000

Quarters > 1 > cash Flow > capital Expenditures

650000

Quarters > 1 > cash Flow > cash From Investing

34923000

Quarters > 1 > cash Flow > cash From Financing

49656000

Quarters > 1 > cash Flow > net Change In Cash

59237000

Quarters > 1 > ratios > PE

-0.07951950032461745

Quarters > 1 > ratios > PB

10.14526207796117

Quarters > 1 > ratios > ROE

-13.673663916979024

Quarters > 1 > ratios > ROA

-4.087452064185788

Quarters > 1 > ratios > FCF

-25992000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-0.26614240953492657

Quarters > 1 > health Score

12

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

74114000

Quarters > 2 > income Statement > cost Of Revenue

12303000

Quarters > 2 > income Statement > gross Profit

61811000

Quarters > 2 > income Statement > operating Expenses

98160000

Quarters > 2 > income Statement > operating Income

-36349000

Quarters > 2 > income Statement > interest Expense

6262000

Quarters > 2 > income Statement > pretax Income

-40285000

Quarters > 2 > income Statement > net Income

-41144000

Quarters > 2 > income Statement > eps

-0.17242188547673326

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

238624000

Quarters > 2 > income Statement > income Tax Expense

859000

Quarters > 2 > income Statement > EBITDA

-33421000

Quarters > 2 > income Statement > operating Margin

-49.04471489866962

Quarters > 2 > income Statement > total Other Income Expense Net

-3936000

Quarters > 2 > balance Sheet > cash

30808000

Quarters > 2 > balance Sheet > short Term Investments

183144000

Quarters > 2 > balance Sheet > receivables

46467000

Quarters > 2 > balance Sheet > inventories

23776000

Quarters > 2 > balance Sheet > total Current Assets

312692000

Quarters > 2 > balance Sheet > property Plant Equipment

5335000

Quarters > 2 > balance Sheet > total Assets

410194000

Quarters > 2 > balance Sheet > payables

13722000

Quarters > 2 > balance Sheet > short Term Debt

1302000

Quarters > 2 > balance Sheet > long Term Debt

151301000

Quarters > 2 > balance Sheet > total Liabilities

264518000

Quarters > 2 > balance Sheet > equity

145676000

Quarters > 2 > cash Flow > net Income

-41144000

Quarters > 2 > cash Flow > depreciation

602000

Quarters > 2 > cash Flow > change In Working Capital

-10845000

Quarters > 2 > cash Flow > cash From Operations

-38457000

Quarters > 2 > cash Flow > capital Expenditures

325000

Quarters > 2 > cash Flow > cash From Investing

2851000

Quarters > 2 > cash Flow > cash From Financing

1482000

Quarters > 2 > cash Flow > net Change In Cash

-34124000

Quarters > 2 > ratios > PE

-0.17242188547673326

Quarters > 2 > ratios > PB

9.664471841621133

Quarters > 2 > ratios > ROE

-28.243499272357838

Quarters > 2 > ratios > ROA

-10.030375870929365

Quarters > 2 > ratios > FCF

-38782000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.5232749547993631

Quarters > 2 > health Score

17

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

116129000

Quarters > 3 > income Statement > cost Of Revenue

18264000

Quarters > 3 > income Statement > gross Profit

97865000

Quarters > 3 > income Statement > operating Expenses

89740000

Quarters > 3 > income Statement > operating Income

8125000

Quarters > 3 > income Statement > interest Expense

5853000

Quarters > 3 > income Statement > pretax Income

4680000

Quarters > 3 > income Statement > net Income

4645000

Quarters > 3 > income Statement > eps

0.019032937783403824

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

244050606

Quarters > 3 > income Statement > income Tax Expense

35000

Quarters > 3 > income Statement > EBITDA

11048000

Quarters > 3 > income Statement > operating Margin

6.996529721258256

Quarters > 3 > income Statement > total Other Income Expense Net

-3445000

Quarters > 3 > balance Sheet > cash

64932000

Quarters > 3 > balance Sheet > short Term Investments

185168000

Quarters > 3 > balance Sheet > receivables

57705000

Quarters > 3 > balance Sheet > inventories

21173000

Quarters > 3 > balance Sheet > total Current Assets

356452000

Quarters > 3 > balance Sheet > property Plant Equipment

3875000

Quarters > 3 > balance Sheet > total Assets

435754000

Quarters > 3 > balance Sheet > payables

16000000

Quarters > 3 > balance Sheet > short Term Debt

1562000

Quarters > 3 > balance Sheet > long Term Debt

150853000

Quarters > 3 > balance Sheet > total Liabilities

262465000

Quarters > 3 > balance Sheet > equity

173289000

Quarters > 3 > cash Flow > net Income

4645000

Quarters > 3 > cash Flow > depreciation

515000

Quarters > 3 > cash Flow > change In Working Capital

-6225000

Quarters > 3 > cash Flow > cash From Operations

9810000

Quarters > 3 > cash Flow > capital Expenditures

593000

Quarters > 3 > cash Flow > cash From Investing

-41620000

Quarters > 3 > cash Flow > cash From Financing

49313000

Quarters > 3 > cash Flow > net Change In Cash

17503000

Quarters > 3 > ratios > PE

0.019032937783403824

Quarters > 3 > ratios > PB

8.309232411751468

Quarters > 3 > ratios > ROE

2.680493280012003

Quarters > 3 > ratios > ROA

1.065968413370847

Quarters > 3 > ratios > FCF

9217000

Quarters > 3 > ratios > Piotroski FScore

4

Quarters > 3 > ratios > fcf Percent

0.07936863315795366

Quarters > 3 > health Score

42

Valuation > metrics > PE

-0.004005648303078611

Valuation > metrics > PB

9.251099308400311

Valuation > final Score

20

Valuation > verdict

208.4% Overvalued

Profitability > metrics > ROE

-0.6280788177339901

Profitability > metrics > ROA

-0.2633259507860375

Profitability > metrics > Net Margin

-0.008782822286071659

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

2.1512185636505055

Risk > metrics > Interest Coverage

0.8053830227743272

Risk > final Score

21

Risk > verdict

High

Liquidity > metrics > Current Ratio

18.561664564943253

Liquidity > metrics > Quick Ratio

17.291954602774275

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

40

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

15

Prev Risks > 0

9

Prev Risks > 1

7

Prev Risks > 2

36

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:26:00.247Z